Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Precision medicine in hemato-oncology - treatment of refractory multiple myeloma with massive extramedullary involvement using BRAF/ MEK inhibitors.
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2025
Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
New developments in intracranial stereotactic radiotherapy for metastases.
Clinical oncology (Royal College of Radiologists (Great Britain))·2015
Achieving the relocation accuracy of stereotactic frame-based cranial radiotherapy in a three-point thermoplastic shell.
Clinical oncology (Royal College of Radiologists (Great Britain))·2012
Evaluating safety: Number needed to harm analyses of androgen receptor inhibitors in advanced prostate cancer.
European journal of cancer (Oxford, England : 1990)·2026
Integrating patient preferences into clinical trial outcomes for older adults with cancer: A perspective from the EORTC Older Adult Council and Quality of Life Group.
European journal of cancer (Oxford, England : 1990)·2026
Immune remodelling and molecular profiling of progressive brain metastases following cranial radiotherapy.
European journal of cancer (Oxford, England : 1990)·2026
Neurocognitive functioning in long-term survivors of glioblastoma, IDH-wildtype and astrocytoma, IDH-mutant, CNS WHO grade 4: A report from EORTC 1419 (ETERNITY).
European journal of cancer (Oxford, England : 1990)·2026
AI-generated smoking prevention videos on Instagram achieve greater reach when short-term consequences are addressed.
European journal of cancer (Oxford, England : 1990)·2026
Neoadjuvant chemotherapy reduces regulatory T-cells in cervical cancer.
European journal of cancer (Oxford, England : 1990)·2026
The microbiota-host metabolic axis in cervical cancer: from homeostatic disruption to mechanisms of therapy resistance.
Frontiers in cellular and infection microbiology·2026
Oncometabolites in Cancer Metabolism: Mechanistic Insights and Biomarker Potential- A Narrative Review.
Health science reports·2026